Skip to main content
OpenTrials
Completed

NCT Number: NCT05937555

Professional Bladder Cancers and the Profession of Painter

This is a retrospective study on bladder cancer in French painters' population. The French agency ANSES collected data from all occupational and environmental diseases center in a specific database called RNV3P. We selected cases of bladder cancer in painters in four centers from 01/01/2010 to 31/12/2019. Those cases were analyzed in terms of occupational exposure, histology and sociodemographics data. Comparison between different histologic types of cancer, workplaces and occupational diseases process will be done.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Bladder Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Neoplasms Neoplasms by Site Urinary Bladder Diseases Urinary Bladder Neoplasms Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU de Brest, Brest, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • painters
  • age> 18 years
  • data from one of the French occupational diseases centers
  • approval letter

Exclusion criteria

  • non-approval letter
  • age < 18 years

Treatment and study plan

Primary outcomes

  1. histological type of bladder cancer

    Time frame: Inclusion ( Day 0)

    international classification of bladder cancer TNM and histology

Secondary outcomes

  1. Occupational exposures

    Time frame: Inclusion (Day 0)

    chemical exposures and workplaces during occupational painting activities

Sponsors and collaborators

Lead sponsor

University Hospital, Brest

Other

Registry information

Official study title

Professional Bladder Cancers and the Profession of Painter: Retrospective Study of the RNV3P Database Files

Acronym: NEVPP

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jul 10, 2023
Registry last updated
Jul 10, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.